Berkeley Lights, Inc. operates as a biotechnology company. The Company provides technology solutions for single cell manipulation for biopharma, diagnostics, and life science research. Berkeley Lights serves customers worldwide.

Company profile
Ticker
BLI
Exchange
Website
CEO
Eric Hobbs
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Agilent • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Bruker • Perkinelmer • Seer • Cue Health ...
SEC CIK
Corporate docs
Subsidiaries
BLI Europe International, Ltd. • BLI International LLC • (Shanghai) Co., Ltd. • (Singapore) Pte., Ltd. ...
IRS number
352415390
BLI stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
26 Jan 23
425
Business combination disclosure
9 Jan 23
8-K
Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
9 Jan 23
425
Business combination disclosure
4 Jan 23
425
Business combination disclosure
23 Dec 22
425
Business combination disclosure
22 Dec 22
425
Business combination disclosure
22 Dec 22
425
Business combination disclosure
21 Dec 22
425
Business combination disclosure
21 Dec 22
8-K
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
21 Dec 22
Transcripts
BLI
Earnings call transcript
2022 Q3
9 Nov 22
BLI
Earnings call transcript
2022 Q2
10 Aug 22
BLI
Earnings call transcript
2022 Q1
10 May 22
BLI
Earnings call transcript
2021 Q4
24 Feb 22
BLI
Earnings call transcript
2021 Q3
4 Nov 21
BLI
Earnings call transcript
2021 Q2
11 Aug 21
BLI
Earnings call transcript
2021 Q1
11 May 21
BLI
Earnings call transcript
2020 Q4
28 Feb 21
BLI
Earnings call transcript
2020 Q3
12 Nov 20
Latest ownership filings
4
James Paul McClaskey
24 Jan 23
4
Siddhartha Kadia
13 Dec 22
4
Siddhartha Kadia
9 Dec 22
4
James Paul McClaskey
22 Nov 22
4
Eric Hobbs
22 Nov 22
4
Keith Breinlinger
22 Nov 22
4
James Paul McClaskey
24 Oct 22
4
Scott David Chaplin
21 Sep 22
3
Scott David Chaplin
21 Sep 22
4
Keith Breinlinger
19 Sep 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 120.64 mm | 120.64 mm | 120.64 mm | 120.64 mm | 120.64 mm | 120.64 mm |
Cash burn (monthly) | 7.46 mm | 6.39 mm | 7.18 mm | 7.21 mm | 5.64 mm | 4.33 mm |
Cash used (since last report) | 29.55 mm | 25.29 mm | 28.44 mm | 28.57 mm | 22.33 mm | 17.13 mm |
Cash remaining | 91.09 mm | 95.35 mm | 92.20 mm | 92.07 mm | 98.31 mm | 103.51 mm |
Runway (months of cash) | 12.2 | 14.9 | 12.8 | 12.8 | 17.4 | 23.9 |
Institutional ownership, Q3 2022
77.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 102 |
Opened positions | 12 |
Closed positions | 31 |
Increased positions | 31 |
Reduced positions | 35 |
13F shares | Current |
---|---|
Total value | 285.43 mm |
Total shares | 52.78 mm |
Total puts | 12.30 k |
Total calls | 19.00 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Igor Y Khandros | 8.78 mm | $159.68 mm |
ARK Investment Management | 5.47 mm | $15.64 mm |
BLK Blackrock | 4.96 mm | $14.18 mm |
MKFCF Mackenzie Financial | 4.18 mm | $11.96 mm |
Baillie Gifford & Co | 3.72 mm | $10.63 mm |
Vanguard | 3.07 mm | $8.79 mm |
Glenview Capital Management | 2.33 mm | $6.65 mm |
FHI Federated Hermes | 2.18 mm | $6.22 mm |
Nierenberg Investment Management | 2.06 mm | $5.90 mm |
JPM JPMorgan Chase & Co. | 1.62 mm | $4.63 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Jan 23 | James Paul McClaskey | Common Stock | Payment of exercise | Dispose F | No | No | 2.22 | 143 | 317.46 | 65,072 |
9 Dec 22 | Siddhartha Kadia | Common Stock | Payment of exercise | Dispose F | No | No | 2.64 | 36,975 | 97.61 k | 923,660 |
7 Dec 22 | Siddhartha Kadia | Common Stock | Payment of exercise | Dispose F | No | No | 2.53 | 150 | 379.50 | 960,635 |
20 Nov 22 | Keith Breinlinger | Common Stock | Payment of exercise | Dispose F | No | No | 2.93 | 1,565 | 4.59 k | 151,743 |
20 Nov 22 | Keith Breinlinger | Common Stock | Payment of exercise | Dispose F | No | No | 2.93 | 4,015 | 11.76 k | 153,308 |
20 Nov 22 | Keith Breinlinger | Common Stock | Payment of exercise | Dispose F | No | No | 2.93 | 119 | 348.67 | 157,323 |
20 Nov 22 | Eric Hobbs | Common Stock | Payment of exercise | Dispose F | No | No | 2.93 | 23,011 | 67.42 k | 129,201 |
20 Nov 22 | Eric Hobbs | Common Stock | Payment of exercise | Dispose F | No | No | 2.93 | 478 | 1.40 k | 152,212 |
News
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Jan 23
Berkeley Lights' Preliminary 2022 Results Deficient, Analysts Say All Eyes On IsoPlexis Execution
10 Jan 23
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
10 Jan 23
12 Health Care Stocks Moving In Monday's After-Market Session
9 Jan 23
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
23 Dec 22
Press releases
Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
9 Jan 23
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
9 Jan 23
Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference
3 Jan 23
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZN, BLI, ISO, CBIO
3 Jan 23
ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO
30 Dec 22